Expression and mutational profile of BCR-ABL gene in patients with chronic mieloid leukemia treated with tyrosine kinase inhibitors
Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico === Most patients with chronic myeloid leukemia (CML) express the transcripts b2a2, b3a2 or both of the BCR-ABL gene. The role of these transcripts in the prognosis of patients undergoing treatment with tyrosine kinase inhibitors (ITKs) h...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | Portuguese |
| Published: |
Universidade Federal do CearÃ
2017
|
| Subjects: | |
| Online Access: | http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=19145 |